Anna Novarino

1.5k total citations
43 papers, 1.1k citations indexed

About

Anna Novarino is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Anna Novarino has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Anna Novarino's work include Pancreatic and Hepatic Oncology Research (9 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Anna Novarino is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Anna Novarino collaborates with scholars based in Italy, United Kingdom and Malaysia. Anna Novarino's co-authors include Graziella Bellone, Libero Ciuffreda, Oscar Bertetto, Michèle Milella, Alice Giacobino, Aldo Scarpa, Mirella Giovarelli, Paola Nisticò, Francesco Novelli and Paola Cappello and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Annals of Oncology.

In The Last Decade

Anna Novarino

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Novarino Italy	19	577	319	294	197	180	43	1.1k
Cristiana Carniti Italy	21	439 0.8×	314 1.0×	396 1.3×	392 2.0×	169 0.9×	59	1.2k
Mirosław Majewski Poland	16	456 0.8×	292 0.9×	522 1.8×	308 1.6×	279 1.6×	28	1.4k
Eric Raefsky United States	14	396 0.7×	137 0.4×	158 0.5×	195 1.0×	116 0.6×	46	835
Gisele W. B. Colleoni Brazil	21	590 1.0×	428 1.3×	678 2.3×	432 2.2×	152 0.8×	85	1.5k
Martin Poleski United States	12	548 0.9×	170 0.5×	357 1.2×	83 0.4×	231 1.3×	18	1.2k
Pascale De Paepe Belgium	15	387 0.7×	233 0.7×	268 0.9×	140 0.7×	285 1.6×	36	999
Han Myint United States	14	456 0.8×	453 1.4×	321 1.1×	305 1.5×	245 1.4×	30	1.1k
Mahesh Seetharam United States	15	408 0.7×	162 0.5×	276 0.9×	261 1.3×	125 0.7×	62	922
I Tepler United States	11	681 1.2×	136 0.4×	217 0.7×	332 1.7×	61 0.3×	19	1.1k
Craig J. Reist United States	17	492 0.9×	245 0.8×	361 1.2×	80 0.4×	180 1.0×	27	1.4k

Countries citing papers authored by Anna Novarino

Since Specialization

Citations

This map shows the geographic impact of Anna Novarino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Novarino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Novarino more than expected).

Fields of papers citing papers by Anna Novarino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Novarino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Novarino. The network helps show where Anna Novarino may publish in the future.

Co-authorship network of co-authors of Anna Novarino

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Novarino. A scholar is included among the top collaborators of Anna Novarino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Novarino. Anna Novarino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cereda, Stefano, Michèle Milella, Stefano Cordio, et al.. (2015). Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma. Cancer Chemotherapy and Pharmacology. 77(1). 109–114. 12 indexed citations

Capello, Michela, Paola Cappello, Federica Linty, et al.. (2013). Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. Journal of Hematology & Oncology. 6(1). 67–67. 36 indexed citations

Vizio, Barbara, Fiorella Biasi, Anna Novarino, et al.. (2013). Pancreatic-carcinoma-cell-derived pro-angiogenic factors can induce endothelial-cell differentiation of a subset of circulating CD34+ progenitors. Journal of Translational Medicine. 11(1). 314–314. 20 indexed citations

Novarino, Anna, Maria Antonietta Satolli, Isabella Chiappino, et al.. (2012). FOLFOX-4 Regimen or Single-agent Gemcitabine as First-line Chemotherapy in Advanced Biliary Tract Cancer. American Journal of Clinical Oncology. 36(5). 466–471. 11 indexed citations

Vizio, Barbara, et al.. (2010). Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results. Cancer Science. 101(11). 2448–2454. 21 indexed citations

Cappello, Paola, Michela Capello, Claudia Fredolini, et al.. (2010). Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer. Journal of Proteome Research. 10(1). 105–112. 106 indexed citations

Novarino, Anna, Maria Antonietta Satolli, Isabella Chiappino, et al.. (2009). Oxaliplatin, 5-Fluorouracil, and Leucovorin as Second-Line Treatment for Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 32(1). 44–48. 28 indexed citations

Cappello, Paola, Roberto Chiarle, Patrizia Ceruti, et al.. (2009). An integrated humoral and cellular response is elicited in pancreatic cancer by α‐enolase, a novel pancreatic ductal adenocarcinoma‐associated antigen. International Journal of Cancer. 125(3). 639–648. 96 indexed citations

Foà, Robert, Giovanna Meloni, S. Tosti, et al.. (2008). Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study. British Journal of Haematology. 77(4). 491–496. 7 indexed citations

10.

Bellone, Graziella, Anna Carbone, Carlo Smirne, et al.. (2006). Cooperative Induction of a Tolerogenic Dendritic Cell Phenotype by Cytokines Secreted by Pancreatic Carcinoma Cells. The Journal of Immunology. 177(5). 3448–3460. 105 indexed citations

11.

Bellone, Graziella, Anna Carbone, Carlo Smirne, et al.. (2006). Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line capan-2. Cancer Biology & Therapy. 5(10). 1294–1303. 8 indexed citations

12.

Bellone, Graziella, Anna Novarino, Isabella Chiappino, et al.. (2005). Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy.. PubMed. 25(5). 3287–91. 11 indexed citations

13.

Novarino, Anna, Isabella Chiappino, Gianfilippo Bertelli, et al.. (2004). Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer. Annals of Oncology. 15(3). 474–477. 22 indexed citations

14.

Tarella, Corrado, Claudia Castellino, Francesco Locatelli, et al.. (1998). G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs. Bone Marrow Transplantation. 21(4). 401–407. 52 indexed citations

15.

Pivetti, S, et al.. (1995). Hepatitis C virus infection in patients with haematological diseases: evidence for the association with erythrocytes transfusion and liver disease. International Hepatology Communications. 4(1). 9–15. 1 indexed citations

16.

Guarini, Anna, F Sanavio, Anna Novarino, et al.. (1991). Thrombocytopenia in acute leukaemia patients treated with IL2: cytolytic effect of LAK cells on megakaryocytic progenitors. British Journal of Haematology. 79(3). 451–456. 13 indexed citations

17.

Meloni, Giovanni Battista, S. Tosti, Anna Novarino, et al.. (1990). Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings.. PubMed. 6 Suppl 1. 98–102. 11 indexed citations

18.

Aglietta, Massimo, Wanda Piacibello, Alessandra Stacchini, et al.. (1984). Differences in the in vitro growth pattern of fresh and cryopreserved granulo-monopoietic precursors. Cryobiology. 21(5). 486–490. 5 indexed citations

19.

Sardi, Armando, et al.. (1983). Thrombotic thrombocytopenic purpura successfully treated by plasma exchange: a report of two cases.. PubMed. 68(3). 392–8. 1 indexed citations

20.

Cappio, F. Caligaris, Giovanni Camussi, Anna Novarino, et al.. (1981). Immune‐Complexes (IC) in Idiopathic Neutropenia. Scandinavian Journal of Haematology. 27(5). 311–322. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact